Option Care Health director acquires 3,411 OPCH shares near $29.31

Rhea-AI Filing Summary

Option Care Health director Norman L. Wright purchased 3,411 shares of OPCH common stock on 09/09/2025 at a weighted average price of $29.3099 per share, with individual purchase prices ranging from $29.28 to $29.31. After the transactions, the reporting person beneficially owned 15,501 shares. The Form 4 was signed by Michael Shapiro as attorney-in-fact on 09/10/2025. No derivative securities were reported in this filing.

Positive

• Director purchase disclosed: Norman L. Wright acquired 3,411 shares, increasing his stake to 15,501 shares.
• Transparent pricing: Filing reports a weighted average price of $29.3099 and a purchase price range of $29.28 to $29.31.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: A company director modestly increased direct share ownership, signalling personal capital allocation into the issuer.

The director-level purchase of 3,411 shares at roughly $29.31 per share increases direct ownership to 15,501 shares. Such insider purchases are commonly interpreted as an alignment of personal and shareholder interests and can be viewed as a routine, non-material governance event absent additional context. The filing shows no exercises, grants, or dispositions and includes an explicit price range for the transactions, which increases transparency.

Securities Analyst

TL;DR: Insider purchase disclosed; transaction size appears modest relative to typical market-cap scale and shows no hedging or derivative activity.

The Form 4 documents an open-market acquisition of 3,411 common shares executed on a single date with a weighted average price of $29.3099 and a disclosed price range of $29.28 to $29.31. The ownership post-transaction is 15,501 shares. There are no derivative positions reported, so the exposure is straightforward equity ownership. This is a clear, routine disclosure of insider buying with limited standalone impact on valuation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Norman L.

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		P		3,411	A	$29.3099(1)	15,501	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 3,411 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on September 9, 2025 with purchase prices ranging from $29.28 to $29.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Michael Shapiro, attorney-in-fact for Mr. Wright	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OPCH director Norman L. Wright buy on 09/09/2025?

The director purchased 3,411 shares of Option Care Health common stock on 09/09/2025.

At what price were the OPCH shares purchased by the director?

The weighted average purchase price was $29.3099 per share, with individual purchase prices ranging from $29.28 to $29.31.

How many OPCH shares does the reporting person beneficially own after the transaction?

After the reported purchases the reporting person beneficially owned 15,501 shares.

Were any derivative securities reported in this Form 4 for OPCH?

No. The filing shows no derivative securities; only non-derivative common stock purchases were disclosed.

Who signed the Form 4 for Norman L. Wright and when?

The Form 4 was signed by Michael Shapiro, attorney-in-fact for Mr. Wright on 09/10/2025.